Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

RUMA defends veterinary use of antibiotics
cow
It's critical that potential impacts on welfare, food safety, product quality and investment are fully understood by the businesses involved.
Investors urge food companies to stop suppliers using critical drugs

Non-profit group RUMA has defended the use of antibiotics in farming, after recent reports that a group of investors contacted food companies, urging them to 'stop their meat and poultry suppliers using antibiotics vital for human health'.

RUMA (Responsible Use of Medicines in Agriculture Alliance), said that whilst it welcomes food companies and suppliers working together to reduce the need for antibiotics in farm animals, it is vital that the potential impacts are understood.

'The concept that food companies work sustainably with their supply chains to reduce the need for antibiotics is welcomed by RUMA; this is already happening.

'However, it's critical that potential impacts on welfare, food safety, product quality and investment are fully understood by the businesses involved, so that farmers have the confidence, means and support to make any necessary changes.'

Equally, the group said it is important the issue is not exploited as a 'marketing tool'.

'There is a risk that misrepresentation of the facts and a failure to appreciate the situation in different countries could end up harming welfare, cause unnecessary suffering and lead to significant losses in our farm livestock sector.'

It is reported that 70 per cent of antibiotics in the US may be used to tackle disease challenges, whereas in the UK the figure is only 40 per cent. Public Health England figures show that the medical use of antibiotics is in fact 2.4 times higher than that of veterinary.

'Furthermore, use of antibiotics as growth promotors has been banned in the EU since 2006; antibiotics are only available in the UK on prescription from vets; and the industry has already opted for restrictions to use a number of antibiotics classed as critically important for human health, such as third and fourth generation cephalosporins, fluoroquinolones and colistin, only when truly necessary.'

 

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.